UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 15, 2003
Lifecore Biomedical, Inc.
(Exact name of Registrant as specified in its charter)
| | | | | |
| Minnesota | | 0-4136 | | 41-0948334 |
(State or other jurisdiction of | |
(Commission File Number) | |
(IRS Employer Identification No.) |
| incorporation or organization) | | | | |
| | | |
| 3515 Lyman Boulevard | | |
| Chaska, Minnesota | | 55318 |
(Address of principal executive | |
(Zip Code) |
| offices) | | |
Registrant’s telephone number, including area code: 952-368-4300
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits.
| | | |
| Exhibit # | | Description |
99.1 | |
Press Release of the registrant, dated April 15, 2003 |
Item 9. Regulation FD Disclosure.
On April 15, 2003, Lifecore Biomedical, Inc., a Minnesota corporation (the “Company”), issued a press release stating “Lifecore Reports Third Quarter Financial Results”. The attached exhibit is furnished pursuant to Item 12 on Form 8-K.
Reference is made to the Registrant's Press Release, dated April 15, 2003, which is included herewith as Exhibit 99.1. The attached Exhibit is furnished pursuant to Item 12 on Form 8-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | | | LIFECORE BIOMEDICAL, INC. |
| | | | | |
| | | | | |
| Dated: | | April 17, 2003 | | /s/ James W. Bracke |
| | | |
James W. Bracke |
| | | | | President & Chief Executive Officer |
